The Institute@Precision exists to accelerate the future of precision medicine by transforming biopharma expertise into accessible knowledge.
We convene the real-world voices shaping innovation – from scientists to former regulators to commercial leaders – and focus them on the most pressing challenges facing our industry. Each quarter, we take a deep dive into a single critical topic, offering not just information, but actionable insight. I@P is not a library – it's a conversation, a community, and a catalyst for progress.
Insights drawn from our deep experience
across the biopharma lifecycle
150+
25+
425+
Q4 2025 Topic: ADCs
ADCs Deep Dive
Since the first ADC approval 25 years ago, they have revolutionized oncology treatment. What can we learn from a quarter century of R&D breakthroughs and failures, and from the commercialization and access strategies these drugs have used?
1H 2026 Topic: Radiopharmaceuticals
Radiopharmaceuticals Deep Dive
Radiopharmaceuticals present enormous promise for the next generation of oncology treatments. How can we address the clinical, logistical, manufacturing, and other challenges these therapies present?
Precision for Medicine
Precision AQ
Precision Medicine Group was founded to transform the process of bringing new drugs to market by integrating science, technology, data, and human expertise. We work to address the fundamental changes in healthcare necessary for global health and outcomes improvement.
